ATE366256T1 - Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren - Google Patents

Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren

Info

Publication number
ATE366256T1
ATE366256T1 AT99938846T AT99938846T ATE366256T1 AT E366256 T1 ATE366256 T1 AT E366256T1 AT 99938846 T AT99938846 T AT 99938846T AT 99938846 T AT99938846 T AT 99938846T AT E366256 T1 ATE366256 T1 AT E366256T1
Authority
AT
Austria
Prior art keywords
protein coupled
nucleic acids
coupled receptor
acids coding
receptor involved
Prior art date
Application number
AT99938846T
Other languages
English (en)
Inventor
Charles Zuker
Jon Adler
Juergen Lindemeier
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE366256T1 publication Critical patent/ATE366256T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99938846T 1998-07-28 1999-07-27 Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren ATE366256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9546498P 1998-07-28 1998-07-28
US11274798P 1998-12-17 1998-12-17

Publications (1)

Publication Number Publication Date
ATE366256T1 true ATE366256T1 (de) 2007-07-15

Family

ID=26790259

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07008610T ATE474852T1 (de) 1998-07-28 1999-07-27 Nukleinsäuren, die für einen an ein g-protein gekoppelten, an der sensorischen transduktion beteiligten rezeptor kodieren
AT99938846T ATE366256T1 (de) 1998-07-28 1999-07-27 Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07008610T ATE474852T1 (de) 1998-07-28 1999-07-27 Nukleinsäuren, die für einen an ein g-protein gekoppelten, an der sensorischen transduktion beteiligten rezeptor kodieren

Country Status (15)

Country Link
US (8) US6383778B1 (de)
EP (1) EP1100811B1 (de)
JP (2) JP4657450B2 (de)
KR (1) KR100643622B1 (de)
CN (1) CN1178952C (de)
AT (2) ATE474852T1 (de)
AU (2) AU764180B2 (de)
BR (1) BR9912437A (de)
CA (1) CA2335376C (de)
DE (2) DE69936453T2 (de)
DK (1) DK1100811T3 (de)
ES (1) ES2289817T3 (de)
IL (3) IL140980A0 (de)
NO (1) NO20010320L (de)
WO (1) WO2000006593A1 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7654728B2 (en) * 1997-10-24 2010-02-02 Revalesio Corporation System and method for therapeutic application of dissolved oxygen
US20110075507A1 (en) * 1997-10-24 2011-03-31 Revalesio Corporation Diffuser/emulsifier
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
CN1178952C (zh) 1998-07-28 2004-12-08 加利福尼亚大学董事会 编码与感觉转导有关的g-蛋白偶联受体的核酸
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US7588900B2 (en) 2001-07-03 2009-09-15 The Regents Of The University Of California Mammalian sweet and amino acid heterodimeric taste receptors
US6875574B1 (en) * 1999-01-27 2005-04-05 The Regents Of The University Of California Assays for sensory modulators using a sensory cell specific G-protein alpha subunit
GB9923146D0 (en) * 1999-09-30 1999-12-01 Imperial College Detector array
TW201006846A (en) * 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
ES2250369T3 (es) * 2000-03-14 2006-04-16 Amgen Inc. Receptor acoplado a la proteina g.
WO2001077676A1 (en) 2000-04-07 2001-10-18 Senomyx, Inc. T2r taste receptors and genes encoding same
US7678539B2 (en) 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
US6977155B2 (en) * 2000-08-10 2005-12-20 Corning Incorporated Arrays of biological membranes and methods and use thereof
ES2348786T3 (es) * 2000-09-22 2010-12-14 Chemcom S.A. Receptores olfativos y de feromonas acoplados a la proteina g.
TW201022287A (en) * 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7368285B2 (en) 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US6955887B2 (en) * 2001-03-30 2005-10-18 Senomyx, Inc. Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling
US7763431B1 (en) 2001-03-07 2010-07-27 Senomyx, Inc. Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste
US20080244761A1 (en) * 2001-03-07 2008-10-02 Senomyx, Inc. T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
US7301009B2 (en) 2001-06-26 2007-11-27 Senomyx, Inc. Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
US7309577B2 (en) 2001-03-07 2007-12-18 Senomyx, Inc. Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
US7338771B2 (en) 2001-07-10 2008-03-04 Alexey Pronin Use of specific T2R taste receptors to identify compounds that block bitter taste
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
EP1572871A4 (de) * 2001-04-20 2007-11-14 Sinai School Medicine T1r3, ein neuer geschmacksrezeptor
CN100489102C (zh) * 2001-06-26 2009-05-20 塞诺米克斯公司 T1r异源寡聚的味觉受体和表达所述受体的细胞系及其在鉴定味觉化合物中的用途
IL159243A0 (en) * 2001-06-26 2004-06-01 Senomyx Inc Tir hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
DK2327985T3 (en) * 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
CA2452315A1 (en) 2001-07-06 2003-01-16 Senomyx, Inc. Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
AU2002326436A1 (en) * 2001-07-19 2003-03-03 Icogen Corporation Methods for identification of activators of g protein-coulpled receptors and nucleic acids encoding those receptors
WO2003008627A2 (en) * 2001-07-20 2003-01-30 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Phenylthiocarbamide (ptc) taste receptor
WO2003025137A2 (en) * 2001-09-18 2003-03-27 Irm, Llc Sweet taste receptors
CA2498713A1 (en) * 2002-09-17 2004-04-01 Richard Abraham Joseph Real-time detection of nucleic acid reactions
AU2004258071A1 (en) 2003-06-19 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Variants of human taste receptor genes
EP1639005B1 (de) 2003-06-27 2017-05-03 Monell Chemical Senses Center Geschmacksrezeptoren der t1r-familie aus der hauskatze
US7517968B2 (en) * 2003-07-07 2009-04-14 Syracuse University Rapid and inexpensive method for the purification of proteorhodopsin
NZ545747A (en) * 2003-08-06 2010-06-25 Senomyx Inc T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
US20050106571A1 (en) 2003-10-02 2005-05-19 The Regents Of The University Of California Mammalian T1R3 sweet taste receptors
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US20060257543A1 (en) * 2005-02-04 2006-11-16 Catherine Tachdjian Molecules comprising linked organic moieties as flavor modifiers for comestible compositions
CA2597134C (en) * 2005-02-04 2015-05-26 Senomyx, Inc. Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
US8796441B2 (en) * 2005-04-13 2014-08-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human sweet and umami taste receptor variants
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
WO2007047988A2 (en) 2005-10-20 2007-04-26 Senomyx, Inc. Chimeric human sweet-umami and umami-sweet taste receptors
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
JP6095881B2 (ja) 2006-04-20 2017-03-15 ジボダン エス エー 甘味増強に関する方法
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
EP2010009B1 (de) 2006-04-21 2017-06-14 Senomyx, Inc. Verfahren zur herstellung von festen geschmackstoffzusammensetzungen
US9019300B2 (en) * 2006-08-04 2015-04-28 Apple Inc. Framework for graphics animation and compositing operations
US7777877B2 (en) * 2006-10-20 2010-08-17 California Institute Of Technology High efficiency coupling optics for pumping and detection of fluorescence
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
JP5491185B2 (ja) * 2006-10-25 2014-05-14 リバルシオ コーポレイション 傷のケアおよび処置の方法
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8609148B2 (en) * 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
WO2008052145A2 (en) 2006-10-25 2008-05-02 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
WO2008052143A2 (en) 2006-10-25 2008-05-02 Revalesio Corporation Mixing device and output fluids of same
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
BRPI0815634B1 (pt) 2007-08-21 2024-01-09 Firmenich Incorporated Receptores t2r humanos que respondem a compostos amargos que causam gosto amargo nas composições e seus métodos de produção, bem como método de redução ou alívio do sabor amargo em uma composição, composição de alimento, bebida ou medicamento ou composição de um produto nãocomestível
US9745567B2 (en) * 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
CA2703672A1 (en) * 2007-10-25 2009-04-30 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US20100015235A1 (en) * 2008-04-28 2010-01-21 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US20100303917A1 (en) * 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating cystic fibrosis
US20090227018A1 (en) * 2007-10-25 2009-09-10 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20100029764A1 (en) * 2007-10-25 2010-02-04 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20100009008A1 (en) * 2007-10-25 2010-01-14 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US10125359B2 (en) * 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US20100303918A1 (en) * 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
WO2009134929A2 (en) * 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
BRPI0920430A2 (pt) * 2008-10-22 2019-09-24 Revalesio Corp composições e métodos para tratar condições mediadas por metaloproteinase matriz 9 (mmp9)
US20100098659A1 (en) * 2008-10-22 2010-04-22 Revalesio Corporation Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
CN101763735B (zh) * 2010-02-01 2015-02-25 王茜 可具有负系统损失时间的动态信号控制系统的控制方法
CA3079122A1 (en) 2010-03-26 2011-09-29 Trustees Of Dartmouth College Vista regulatory t cell mediator protein, vista binding agents and use thereof
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
EP2566460A4 (de) 2010-05-07 2015-12-23 Revalesio Corp Zusammensetzungen und verfahren für verbesserte sportliche leistungen und verkürzte erholungszeiten
EP2585476A4 (de) 2010-06-22 2014-01-22 Neogenix Oncology Inc Für dickdarm- und bauchspeicheldrüsenkrebs spezifische antigene und antikörper
CN103347500A (zh) 2010-08-12 2013-10-09 利发利希奥公司 用于治疗tau蛋白病的组合物和方法
EP2622091B1 (de) 2010-09-23 2019-03-13 Precision Biologics, Inc. Peptidomimetika gegen darm- und bauchspeicheldrüsenkrebs
EA036545B1 (ru) 2011-05-25 2020-11-20 Иннейт Фарма, С.А. Анти-kir антитела для лечения воспалительных заболеваний
WO2013022948A1 (en) 2011-08-08 2013-02-14 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
BR112014032276A2 (pt) 2012-06-22 2017-11-28 King S College London construtos de vista-ig e o uso de vista-ig para o tratamento de distúrbios autoimunes, alérgicos e inflamatórios
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
EP3552628A1 (de) 2012-09-07 2019-10-16 The Trustees Of Dartmouth College Vista-modulatoren zur diagnose und behandlung von krebs
EP3336104A1 (de) 2012-12-28 2018-06-20 Precision Biologics, Inc. Humanisierte monoklonale antikörper und verfahren zur verwendung zur diagnose und behandlung von darm- und pankreaskrebs
US9804157B1 (en) 2013-03-15 2017-10-31 Senomyx, Inc. Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives
JP2017502002A (ja) 2013-12-09 2017-01-19 ニューヨーク・ユニバーシティ 抗ブドウ球菌剤の食細胞送達用組成物及び方法
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
AU2014372309C1 (en) 2013-12-24 2017-12-14 Janssen Pharmaceutica Nv Anti-VISTA antibodies and fragments
JP6755640B2 (ja) * 2014-03-28 2020-09-16 味の素株式会社 甘味受容体キメラタンパク質及びその利用
MX389695B (es) 2014-06-11 2025-03-20 Kathy A Green Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
CN107405398A (zh) 2014-12-05 2017-11-28 伊穆奈克斯特股份有限公司 鉴定vsig8作为推定vista受体及其用以产生vista/vsig8激动剂和拮抗剂的用途
CN107922497B (zh) 2015-06-24 2022-04-12 詹森药业有限公司 抗vista抗体和片段
TWI756204B (zh) 2016-02-12 2022-03-01 比利時商楊森製藥公司 抗ｖｉｓｔａ抗體及片段、其用途及鑑定其之方法
BR112018071153A2 (pt) 2016-04-15 2019-04-16 Immunext, Inc. anticorpos anti-vista humano e uso dos mesmos
EP3648769A4 (de) * 2017-06-30 2021-04-07 The Rockefeller University Aus menschlicher darmflora abgeleitete n-acylamide zur behandlung von krankheiten beim menschen
WO2021150686A1 (en) 2020-01-22 2021-07-29 Firmenich Incorporated High-sensitivity detection of gpcr activity and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146501A (en) 1975-12-12 1979-03-27 Henkin Robert I Process for isolating and purifying taste bud receptors for screening and evaluating tastants
US5688662A (en) * 1992-04-09 1997-11-18 Linguagen Corporation Gustducin polynucleotides, vectors, host cells and recombinant methods
US7588900B2 (en) 2001-07-03 2009-09-15 The Regents Of The University Of California Mammalian sweet and amino acid heterodimeric taste receptors
CN1178952C (zh) * 1998-07-28 2004-12-08 加利福尼亚大学董事会 编码与感觉转导有关的g-蛋白偶联受体的核酸
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
US20010037364A1 (en) 2000-05-10 2001-11-01 Michalek Nancy R. Management of enterprise communications

Also Published As

Publication number Publication date
HK1101639A1 (en) 2007-10-18
AU5324199A (en) 2000-02-21
CA2335376A1 (en) 2000-02-10
US7270967B2 (en) 2007-09-18
KR100643622B1 (ko) 2006-11-10
US8071743B2 (en) 2011-12-06
US7282557B2 (en) 2007-10-16
JP2009201525A (ja) 2009-09-10
EP1100811B1 (de) 2007-07-04
CN1178952C (zh) 2004-12-08
US20190018001A1 (en) 2019-01-17
CN1318068A (zh) 2001-10-17
JP2002521050A (ja) 2002-07-16
US20110105741A1 (en) 2011-05-05
US20140065643A1 (en) 2014-03-06
CA2335376C (en) 2013-07-02
DK1100811T3 (da) 2007-11-05
US7863433B2 (en) 2011-01-04
IL140980A (en) 2007-10-31
DE69936453D1 (de) 2007-08-16
AU2003254732A1 (en) 2003-11-20
NO20010320D0 (no) 2001-01-19
KR20010085307A (ko) 2001-09-07
IL140980A0 (en) 2002-02-10
US20020119526A1 (en) 2002-08-29
WO2000006593A1 (en) 2000-02-10
US20120142029A1 (en) 2012-06-07
DE69942622D1 (de) 2010-09-02
JP4657450B2 (ja) 2011-03-23
AU764180B2 (en) 2003-08-14
BR9912437A (pt) 2001-09-25
EP1100811A4 (de) 2002-07-31
US10031129B2 (en) 2018-07-24
EP1100811A1 (de) 2001-05-23
US20030022288A1 (en) 2003-01-30
US8568990B2 (en) 2013-10-29
JP5371567B2 (ja) 2013-12-18
US6383778B1 (en) 2002-05-07
IL184795A0 (en) 2007-12-03
DE69936453T2 (de) 2008-03-06
ATE474852T1 (de) 2010-08-15
NO20010320L (no) 2001-03-28
ES2289817T3 (es) 2008-02-01
US20080249293A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
ATE366256T1 (de) Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
WO2001018050A3 (en) T2r taste receptor family
DE69841908D1 (de) Verfahren zur Bestimmung der Rezeptoraktivität und dafür verwendbare Konstrukte
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
WO2005033125A3 (en) Mammalian t1r3 sweet taste receptors
ATE285472T1 (de) Glucagonrezeptoren
NO20010362L (no) Nukleinsyrer kodende for proteiner som er involvert i sensorisk transduksjon
DE69635998D1 (de) Nachweisverfahren für verbindungen, welche die somatostatin- und insulinproduktion stimulieren
WO1996040040A3 (en) Thrombin receptor homolog
WO1997000952A3 (en) A human edg-2 receptor homolog
MX9709338A (es) Receptor de transmembrana-siete de tipo c5a.
WO2002000719A3 (en) Human and mouse g-protein couipled receptors
WO2002042458A3 (en) G protein coupled receptors
WO2000045179A3 (en) Screening for modulators of g-protein subunit beta 3
NO20011511L (no) Nukleinsyrer som koder for en G-protein gammasubenhet som er involvert i sensorisk transduksjon
DE50115416D1 (de) Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren
EP1806362A3 (de) Nukleinsäuren, die für einen an ein G-Protein gekoppelten, an der sensorischen Transduktion beteiligten Rezeptor kodieren
ATE343634T1 (de) Gaba b-rezeptor-subtypen gaba b-r1c und gaba b-r2 und deren heterodimere
ATE305480T1 (de) G-protein gekoppelter rezeptor
ATE308564T1 (de) Zusammensetzungen und verfahren des synaptischen aktivierungsproteins
DE60129719D1 (de) Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen
ATE443083T1 (de) Kationenleitende gaba-a-rezeptoren und deren verwendung
TW200407334A (en) Trehalose receptor and method of detecting trehalose using the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100811

Country of ref document: EP